Pacifica Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Pacifica Partners's LLY Position: Q3 2026 in Review
Pacifica Partners held its Eli Lilly (LLY) position steady in Q3 2026 at 328 shares worth $377K. The position accounts for 0.11% of the portfolio, ranked #87.
Pacifica Partners first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $510K in Q1 2024. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Pacifica Partners held 328 shares of Eli Lilly worth $377K as of Q3 2026.
- Pacifica Partners left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.11% of Pacifica Partners's portfolio in Q3 2026, its #87 holding.
- Pacifica Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
- Pacifica Partners's Eli Lilly position peaked at $510K in Q1 2024.
- 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.